Back to SNYView full pipeline
Phase 3
Development Phase
3
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Q2 '27
Q2 '27
Competitive Landscape
3 competitors in Type 1 Diabetes Mellitus
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Insulin Glargine (Mandatory background drug)Phase 3
Type 2 Diabetes
gemcitabine/carboplatin plus IniparibPhase 3
Squamous Cell Lung Cancer
Metformin (Background drug)Phase 3
Type 2 Diabetes
Androgen Suppression Therapy and Radiation TherapyPhase 3
Prostate Cancer
LinvoseltamabPhase 3
Multiple Myeloma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
